Thierry Allègre
- Infectious Diseases top 10%
- Virology top 5%
- Hepatology top 10%
- Immunology
- Epidemiology
- Co-authors
- Cécile GoujardLaurence MeyerAlain LafeuilladeGuillaume PénarandaÉlisabeth NicandAlice GuéguenJean–François CadranelRosemary Dray‐Spira
- Topics
- HIV-related health complications and treatments (4 papers)HIV/AIDS Research and Interventions (3 papers)HIV Research and Treatment (2 papers)
- Partner nations
- FranceUnited States
In The Last Decade
Thierry Allègre
14 papers receiving 272 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 168
- Virology 95
- Hepatology 59
- Immunology 51
- Epidemiology 45
Countries citing papers authored by Thierry Allègre
This map shows the geographic impact of Thierry Allègre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Allègre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Allègre more than expected).
Fields of papers citing papers by Thierry Allègre
This network shows the impact of papers produced by Thierry Allègre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Allègre. The network helps show where Thierry Allègre may publish in the future.
Co-authorship network of co-authors of Thierry Allègre
This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Allègre. A scholar is included among the top collaborators of Thierry Allègre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Allègre. Thierry Allègre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 9 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | No More Trouble: Driving a Sustainable City Logistics | 2 |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 45 | |
| 9 | 53 | |
| 10 | 34 | |
| 11 | 43 | |
| 12 | 35 | |
| 13 | 26 | |
| 14 | [Interferon alpha and pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis]. | 17 |
| 15 | 1 | |
| 16 | [Value of thiabendazole in scabies resistant to local treatment in HIV infected patients]. | 0 |
About Thierry Allègre
Thierry Allègre is a scholar working on Business and International Management, Virology and Emergency Medicine, having authored 16 papers that have together received 275 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (4 papers), HIV/AIDS Research and Interventions (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Virology (95 citations), Infectious Diseases (168 citations) and Hepatology (59 citations). Thierry Allègre has collaborated with scholars based in France and United States. Frequent co-authors include Cécile Goujard, Laurence Meyer, Alain Lafeuillade, Guillaume Pénaranda, Élisabeth Nicand, Alice Guéguen, Jean–François Cadranel, Rosemary Dray‐Spira, Christophe Renou and Faroudy Boufassa. Their work appears in journals such as PLoS ONE, AIDS and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.